Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multicenter, Randomized, Controlled Study Comparing Tafluprost/Timolol Fixed Combination with Latanoprost/Timolol Fixed Combination in Primary Open-Angle Glaucoma and Ocular Hypertension.
Suzuki K, Otsuka N, Hizaki H, Hashimoto M, Kuwayama Y; Tafluprost/Timolol Versus Latanoprost/Timolol (TTVLT) Study Group. Suzuki K, et al. Among authors: kuwayama y. Adv Ther. 2018 Jun;35(6):796-808. doi: 10.1007/s12325-018-0718-9. Epub 2018 Jun 5. Adv Ther. 2018. PMID: 29873009 Clinical Trial.
Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study.
Tanihara H, Inoue T, Yamamoto T, Kuwayama Y, Abe H, Suganami H, Araie M; K-115 Clinical Study Group. Tanihara H, et al. Among authors: kuwayama y. Acta Ophthalmol. 2015 Jun;93(4):e254-60. doi: 10.1111/aos.12599. Epub 2014 Dec 9. Acta Ophthalmol. 2015. PMID: 25487877 Free article. Clinical Trial.
[Phase III clinical trial of brimonidine in patients with primary open-angle glaucoma and ocular hypertension--comparison of the effects of brimonidine monotherapy versus timolol monotherapy, or combination brimonidine/prostaglandins therapy versus combination placebo/prostaglandins therapy].
Araie M, Yamazaki Y, Sugiyama K, Kuwayama Y, Tanihara H. Araie M, et al. Among authors: kuwayama y. Nippon Ganka Gakkai Zasshi. 2012 Oct;116(10):955-66. Nippon Ganka Gakkai Zasshi. 2012. PMID: 23285843 Clinical Trial. Japanese.
129 results